Istituto Nazionale Tumori Regina Elena IRCCS - S.C. Oncologia Medica B

Roma

0 studies enrolling now · 2 studies all time

What they study most

Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) — Running, not enrolling
• Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322) — Running, not enrolling